NCB-0846 - HY-100830
Nur noch %1 verfügbar
Catalog #
HY-100830
Ab
93,00 €
NCB-0846 is an orally active, selective inhibitor for Wnt, that inhibits Traf2- and Nck-interacting kinase (TNIK) with an IC50 of 21 nM. NCB-0846 blocks TGF-β signaling pathway by inhibiting SMAD2/3 phosphorylation and nuclear translocation[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-100830/NCB-0846-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-Kinase/protease |
| CAS | 1792999-26-8 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 375.42 |
| Solubility | DMSO : ≥ 30 mg/mL |
| Clinical Information | No Development Reported |
| Target | MAP4K;TGF-beta/Smad;Wnt |
| Application: | Cancer-Kinase/protease |
|---|